Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Res. 2019 Jul 23;79(19):5102–5112. doi: 10.1158/0008-5472.CAN-18-3882

Figure 4. TCR clonality is associated with immune pathway dysregulation in breast tumors.

Figure 4.

A. TCR clonality and richness for individual breast tumors with matched scRNA-seq and TCR-seq data. B. Heatmap of Morisita-Horn similarity index to quantify agreement of CDR3 clonotypes from duplicate TCR-seq data for the same breast tumor and between individual breast tumors. C. Hierarchical heatmap of EVA statistics of inter-cellular heterogeneity for immune pathways in each breast tumor T cell subtype.